Theuer Charles Insider Trades

Insider Trading History

Track insider trading activity for Theuer Charles. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $417k 41,684 shares
Last Trade
Dec 12, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 9,333 shares
$10.84
$10.01
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $0 0 shares
Last Trade
Dec 12, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 9,333 shares
$10.84
$10.01
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $225k 22,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.4k 22,500 shares
$4.15
$10.01
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $1.16k 2,200 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8k 2,200 shares
$8.10
$0.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $225k 22,500 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$566k 22,500 shares
$25.15
$10.01
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
PRESIDENT AND CEO
Holding Value $16.7k 518,300 shares
Last Trade
Mar 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.04M 518,300 shares
$7.80
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
PRESIDENT AND CEO
Holding Value $13.1k 406,417 shares
Last Trade
Oct 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11k 3,500 shares
$3.14
$0.03
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $13.2k 25,000 shares
Last Trade
Jun 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 25,000 shares
$7.11
$0.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $225k 22,500 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 22,500 shares
$17.98
$10.01
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $12.9k 399,417 shares
Last Trade
Apr 27, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$699k 47,000 shares
$14.88
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $11.3k 352,417 shares
Last Trade
Apr 26, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$63.2k 3,999 shares
$15.80
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
PRESIDENT AND CEO
Holding Value $13k 402,917 shares
Last Trade
Apr 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 3,500 shares
$35.60
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $11.1k 344,918 shares
Last Trade
Mar 01, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$145k 4,800 shares
$30.20
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $11k 340,118 shares
Last Trade
Feb 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.16k 200 shares
$30.80
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $10.7k 332,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.3M 332,000 shares
$34.00
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $10.9k 339,918 shares
Last Trade
Jan 18, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$219k 6,800 shares
$32.20
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $10.7k 333,118 shares
Last Trade
Dec 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$593k 23,000 shares
$25.80
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $9.99k 310,118 shares
Last Trade
Nov 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$390k 13,900 shares
$28.07
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $9.54k 296,218 shares
Last Trade
Nov 03, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$278k 9,200 shares
$30.20
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
President And CEO
Holding Value $9.24k 287,018 shares
Last Trade
Nov 02, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$190k 6,000 shares
$31.60
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up